Complete Coding Sequence of a Lineage AY.122 SARS-CoV-2 Virus Strain Detected in Kazakhstan-Reference-Cited by-同舟云学术

Complete Coding Sequence of a Lineage AY.122 SARS-CoV-2 Virus Strain Detected in Kazakhstan

Published:2023-07-18 Issue:7 Volume:12 Page:
ISSN:2576-098X
Container-title:Microbiology Resource Announcements
language:en
Short-container-title:Microbiol Resour Announc

Author:

Usserbayev Bekbolat¹,Abduraimov Yergali¹,Kozhabergenov Nurlan¹,Melisbek Aibarys¹,Shirinbekov Meirzhan¹,Smagul Manar²,Nusupbaуeva Gaukhar²,Nakhanov Aziz¹,Burashev Yerbol¹³^ORCID

Affiliation:

1. Research Institute for Biological Safety Problems, Gvardeyskiy, Kazakhstan

2. Scientific and Practical Center for Sanitary and Epidemiological Expertise and Monitoring Branch of the Republican State Enterprise on the Right of Economic Use, National Center for Public Health of the Ministry of Health of the Republic of Kazakhstan, Almaty, Kazakhstan

3. Faculty of Biology and Biotechnology, Al-Farabi Kazakh National University, Almaty, Kazakhstan

Abstract

We describe the coding-complete genome sequence of a strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) obtained from a patient with symptoms of coronavirus disease 2019 (COVID-19), detected in the Republic of Kazakhstan. According to the Pangolin COVID-19 database, the studied strain, SARS-CoV-2/Human/KAZ/Delta-020/2021, belongs to lineage AY.122 and consists of 29,840 nucleotides.

Funder

Ministry of Education and Science of the Republic of Kazakhstan

Publisher

American Society for Microbiology

Subject

Genetics,Immunology and Microbiology (miscellaneous),Molecular Biology

Link

https://journals.asm.org/doi/pdf/10.1128/mra.00301-23

Reference16 articles.

1. COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses

2. SARS-CoV-2 Genome from the Khyber Pakhtunkhwa Province of Pakistan

3. Coronavirus Genomics and Bioinformatics Analysis

4. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses

5. Origin and evolution of pathogenic coronaviruses